Immunogenicity and tolerance induction in vascularized composite allotransplantation

Vascularized composite allotransplantation (VCA) is the transplantation of multiple tissues such as skin, muscle, bone, nerve, and vessels, as a functional unit (i.e., hand or face) to patients suffering from major tissue trauma and functional deficits. Though the surgical feasibility has been optim...

Full description

Bibliographic Details
Main Authors: Jiahui (Angela) Sun, Aisha Adil, Felor Biniazan, Siba Haykal
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-02-01
Series:Frontiers in Transplantation
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/frtra.2024.1350546/full
_version_ 1797315986348572672
author Jiahui (Angela) Sun
Jiahui (Angela) Sun
Aisha Adil
Aisha Adil
Felor Biniazan
Siba Haykal
Siba Haykal
Siba Haykal
author_facet Jiahui (Angela) Sun
Jiahui (Angela) Sun
Aisha Adil
Aisha Adil
Felor Biniazan
Siba Haykal
Siba Haykal
Siba Haykal
author_sort Jiahui (Angela) Sun
collection DOAJ
description Vascularized composite allotransplantation (VCA) is the transplantation of multiple tissues such as skin, muscle, bone, nerve, and vessels, as a functional unit (i.e., hand or face) to patients suffering from major tissue trauma and functional deficits. Though the surgical feasibility has been optimized, issues regarding graft rejection remains. VCA rejection involves a diverse population of cells but is primarily driven by both donor and recipient lymphocytes, antigen-presenting cells, macrophages, and other immune as well as donor-derived cells. In addition, it is commonly understood that different tissues within VCA, such as the skin, elicits a stronger rejection response. Currently, VCA recipients are required to follow potent and lifelong immunosuppressing regimens to maximize graft survival. This puts patients at risk for malignancies, opportunistic infections, and cancers, thereby posing a need for less perilous methods of inducing graft tolerance. This review will provide an overview of cell populations and mechanisms, specific tissue involved in VCA rejection, as well as an updated scope of current methods of tolerance induction.
first_indexed 2024-03-08T03:11:47Z
format Article
id doaj.art-752b98a9dcca4c67a24f966f4c70635a
institution Directory Open Access Journal
issn 2813-2440
language English
last_indexed 2024-03-08T03:11:47Z
publishDate 2024-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Transplantation
spelling doaj.art-752b98a9dcca4c67a24f966f4c70635a2024-02-13T04:37:03ZengFrontiers Media S.A.Frontiers in Transplantation2813-24402024-02-01310.3389/frtra.2024.13505461350546Immunogenicity and tolerance induction in vascularized composite allotransplantationJiahui (Angela) Sun0Jiahui (Angela) Sun1Aisha Adil2Aisha Adil3Felor Biniazan4Siba Haykal5Siba Haykal6Siba Haykal7Latner Thoracic Surgery Laboratories, University Health Network, Toronto General Hospital, University of Toronto, Toronto, ON, CanadaInstitute of Medical Science, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, CanadaLatner Thoracic Surgery Laboratories, University Health Network, Toronto General Hospital, University of Toronto, Toronto, ON, CanadaInstitute of Medical Science, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, CanadaLatner Thoracic Surgery Laboratories, University Health Network, Toronto General Hospital, University of Toronto, Toronto, ON, CanadaLatner Thoracic Surgery Laboratories, University Health Network, Toronto General Hospital, University of Toronto, Toronto, ON, CanadaInstitute of Medical Science, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, CanadaDivision of Plastic & Reconstructive Surgery, Department of Surgery, University of Toronto, Toronto, ON, CanadaVascularized composite allotransplantation (VCA) is the transplantation of multiple tissues such as skin, muscle, bone, nerve, and vessels, as a functional unit (i.e., hand or face) to patients suffering from major tissue trauma and functional deficits. Though the surgical feasibility has been optimized, issues regarding graft rejection remains. VCA rejection involves a diverse population of cells but is primarily driven by both donor and recipient lymphocytes, antigen-presenting cells, macrophages, and other immune as well as donor-derived cells. In addition, it is commonly understood that different tissues within VCA, such as the skin, elicits a stronger rejection response. Currently, VCA recipients are required to follow potent and lifelong immunosuppressing regimens to maximize graft survival. This puts patients at risk for malignancies, opportunistic infections, and cancers, thereby posing a need for less perilous methods of inducing graft tolerance. This review will provide an overview of cell populations and mechanisms, specific tissue involved in VCA rejection, as well as an updated scope of current methods of tolerance induction.https://www.frontiersin.org/articles/10.3389/frtra.2024.1350546/fullvascularized composite allograft (VCA)immunogenicitygraft rejectiontolerance inductiontissue engineering
spellingShingle Jiahui (Angela) Sun
Jiahui (Angela) Sun
Aisha Adil
Aisha Adil
Felor Biniazan
Siba Haykal
Siba Haykal
Siba Haykal
Immunogenicity and tolerance induction in vascularized composite allotransplantation
Frontiers in Transplantation
vascularized composite allograft (VCA)
immunogenicity
graft rejection
tolerance induction
tissue engineering
title Immunogenicity and tolerance induction in vascularized composite allotransplantation
title_full Immunogenicity and tolerance induction in vascularized composite allotransplantation
title_fullStr Immunogenicity and tolerance induction in vascularized composite allotransplantation
title_full_unstemmed Immunogenicity and tolerance induction in vascularized composite allotransplantation
title_short Immunogenicity and tolerance induction in vascularized composite allotransplantation
title_sort immunogenicity and tolerance induction in vascularized composite allotransplantation
topic vascularized composite allograft (VCA)
immunogenicity
graft rejection
tolerance induction
tissue engineering
url https://www.frontiersin.org/articles/10.3389/frtra.2024.1350546/full
work_keys_str_mv AT jiahuiangelasun immunogenicityandtoleranceinductioninvascularizedcompositeallotransplantation
AT jiahuiangelasun immunogenicityandtoleranceinductioninvascularizedcompositeallotransplantation
AT aishaadil immunogenicityandtoleranceinductioninvascularizedcompositeallotransplantation
AT aishaadil immunogenicityandtoleranceinductioninvascularizedcompositeallotransplantation
AT felorbiniazan immunogenicityandtoleranceinductioninvascularizedcompositeallotransplantation
AT sibahaykal immunogenicityandtoleranceinductioninvascularizedcompositeallotransplantation
AT sibahaykal immunogenicityandtoleranceinductioninvascularizedcompositeallotransplantation
AT sibahaykal immunogenicityandtoleranceinductioninvascularizedcompositeallotransplantation